Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes

Journal of Leukocyte Biology

Volumn 84, Issue 2, 2008, Pages 488-498

  Bosque, Alberto ^a,c   Aguiló, Juan I ^a   Del Rey, Manuel ^b   Paz Artal, Estela ^b   Allende, Luis M ^b   Naval, Javier ^a   Anel, Alberto ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Death receptors; Lymphocyte homeostasis; Lymphocyte proliferation

Indexed keywords

CASPASE; CYCLIN B1; FAS LIGAND; HYDROGEN PEROXIDE; INTERLEUKIN 2; PROTEIN P21; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BLAST CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CYCLE REGULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL DIVISION; FAS LIGAND PROTEIN; HOMEOSTASIS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOPROLIFERATIVE DISORDERS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 48649094565     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0108043     Document Type: Article

References (49)

1. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Nagata, S. (1992) Lymphoproliferation disorder explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
2. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
3. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Srtrober, W., Lenardo, M. J., Puck, J. M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
4. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., de Villartay, J. P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1350.
5. Bidère, N., Su, H. C., Lenardo, M. J. (2006) Genetic disorders of programmed cell death in the immune system. Annu. Rev. Immunol. 24, 321-352.
6. Rieux-Laucat, F., Le Deist, F., Fischer, A. (2003) Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 10, 124-133.
7. Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., Mountz, J. D. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98, 1107-1113.
8. Bi, L. L., Pan, G., Atkinson, T. P., Zheng, L., Dale, J. K., Makris, C., Reddy, V., McDonald, J. M., Siegel, R. M., Puck, J. M., et al. (2007) Dominant inhibition of Fas ligand-mediated apoptosis due to heterozygous mutation associated with ALPS type Ib. BMC Med. Genet. 8, 41.
9. Del Rey, M., Ruiz-Contreras, J., Bosque, A., Calleja, S., Gómez-Rial, J., Roldán, E., Morales, P., Anel, A., Paz-Artal, E., Allende, L. M. (2006) A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood 108, 1306-1312.
10. Oliveira, J. B., Bidère, N., Niemela, J. E., Zheng, L., Sakai, K., Nix, C. P., Danner, R. L., Barb, J., Munson, P. J., Puck, J. M., et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 104, 8953-8958.
11. Martínez-Lorenzo, M. J., Alava, M. A., Gamen, S., Kim, J. K., Chuntharapai, A., Piñeiro, A., Naval, J., Anel, A. (1998) Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28, 2714-2725.
12. -/- mice. Nat. Immunol. 4, 255-260.
13. Muppidi, J. R., Siegel, R. M. (2004) Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 5, 182-189.
14. Strasser, A., Pellegrini, M. (2004) T-lymphocyte death during shutdown of an immune response. Trends Immunol. 25, 610-615.
15. Bosque, A., Pardo, J., Martínez-Lorenzo, M. J., Iturralde, M., Marzo, I., Piñeiro, A., Alava, M. A., Naval, J., Anel, A. (2005) Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL and c-FLIP, Bim or Bcl-x isoform expression. J. Leukoc. Biol. 77, 568-578.
16. + T cell blasts to regulation by APO2L/TRAIL. Eur. J. Immunol. 35, 1812-1821.
17. Kastan, M. B., Bartek, J. (2004) Cell-cycle checkpoints and cancer. Nature 432, 316-323.
18. Taylor, W. R., Stark, G. R. (2001) Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815.
19. Del Rey, M., Manzanares, J., Bosque, A., Aguiló, J. I., Gómez-Rial, J., Roldán, E., Anel, A., Paz-Artal, E., Allende, L. M. (2007) Autoimmune Lymphoproliferative Syndrome (ALPS) in a patient with a new germline Fas gene mutation. Immunobiology 212, 73-83.
20. Renno, T., Attinger, A., Locatelli, S., Bakker, T., Vacheron, S., MacDonald, H. R. (1999) Apoptosis of superantigen-activated T cells occurs prefrentially after a discrete number of cell divisions in vivo. J. Immunol. 162, 6312-6315.
21. Messina, J. P., Lawrence, D. A. (1989) Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J. Immunol. 143, 1974-1981.
22. Miltenyi, S., Muller, W., Weichel, W., Radbruch, A. (1990) High gradient magnetic cell separation with MACS. Cytometry 11, 231-238.
23. Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Ashkenazi, A. (2001) Differential hepatocyte toxicity of recombinant APO2L/TRAIL versions. Nat. Med. 7, 383-385.
24. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., Ashkenazi, A. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690.
25. - T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression. Eur. J. Immunol. 24, 558-565.
26. + T cells responding to a bacterial superantigen. J. Immunol. 154, 4302-4308.
27. Russell, J. H., Wang, R. (1993) Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 23, 2379-2382.
28. Balomenos, D., Martín-Caballero, J., García, M. I., Prieto, I., Flores, J. M., Serrano, M., Martínez-A., C. (2000) The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6, 171-176.
29. CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses1. J. Immunol. 178, 2296-2306.
30. 2 arrest in response to overexpression of p53. Mol. Biol. Cell 10, 3607-3622.
31. Nurse, P. (1990) Universal control mechanism regulation onset of Mphase. Nature 344, 503-508.
32. Monleón, I., Martínez-Lorenzo, M. J., Monteagudo, L., Lasierra, P., Taulés, M., Iturralde, M., Piñeiro, A., Larrad, L., Alava, M. A., Naval, J., et al. (2001) Differential secretion of Fas ligand- or APO2 ligand/TRAIL-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 167, 6736-6744.
33. Alonso, R., Rodríguez, M. C., Pindado, J., Merino, E., Mérida, I., Izquierdo, M. (2005) Diacylglycerolkinase-a regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes. J. Biol. Chem. 280, 28439-28450.
34. Bosque, A., Aguiló, J. I., Alava, M. A., Paz-Artal, E., Naval, J., Allende, L. M., Anel, A. (2007) The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling. Blood 109, 1627-1635.
35. Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355-365.
36. Ashkenazi, A., Dixit, V. M. (1998) Death receptors: Signaling and modulation. Science 281, 1305-1308.
37. Jackson, S. H., Devadas, S., Kwon, J., Pinto, L. A., Williams, M. S. (2004) T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat. Immunol. 5, 818-827.
38. Jezek, P., Hlavata, L. (2005) Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell Biol. 37, 2478-2503.
39. Anel, A., Gamen, S., Alava, M. A., Schmitt-Verhulst, A. M., Piñeiro, A., Naval, J. (1996) Role of oxidative damage and ICE-like proteases in Fas-based cytotoxicity exerted by effector T cells. Int. Immunol. 8, 1173-1183.
40. Bosque, A., Marzo, I., Naval, J., Anel, A. (2007) Apoptosis by IL-2 deprivation in human CD8 T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 loss. Mol. Immunol. 44, 1446-1453.
41. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434, 88-93.
42. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., Beach, D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
43. Lawson, B. R., Baccala, R., Song, J., Kono, D. H., Theofilopoulos, A. N. (2004) Deficiency of the cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J. Exp. Med. 199, 547-557.
44. + T cells. Proc. Natl. Acad. Sci. USA 97, 1707-1712.
45. cip-1/WAF-1, which promotes apoptosis. J. Immunol. 164, 4032-4036.
46. Legembre, P., Barnhart, B. C., Zheng, L., Vijayan, S., Straus, S. E., Puck, J., Dale, J. K., Lenardo, M. J., Peter, M. E. (2004) Induction of apoptosis and activation of NF-κB by CD95 require different signalling thresholds. EMBO Rep. 5, 1084-1089.
47. + T cells. Nat. Med. 4, 1377-1382.
48. Janssen, O., Qian, J., Linkermann, A., Kabelitz, D. (2003) CD95 ligand-death factor and costimulatory molecule? Cell Death Differ. 10, 1215-1225.
49. Nagata, S., Suda, T. (1995) Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43.